Addressing genetic disorders head-on
Our first priority is helping patients with high unmet medical need by advancing transformative AAV-based gene therapy treatments. There’s not a moment to waste. That’s why we set clear objectives, rapidly find targets, identify solutions — and deliver results.
Current Therapeutic Areas of Focus
We are building a pipeline of gene therapies starting with these therapeutic areas.
Caused by disruption of the brain or central nervous system and characterized by abnormal brain function.
Affects the body’s ability to perform standard metabolic processes and functions within the brain or central nervous system
Affects the body’s ability to perform standard metabolic processes
- Target Identification
- Product Optimization
Bardet-Biedl Syndrome (BBS)
With operational support from Jaguar Gene Therapy, Axovia Therapeutics is accelerating the development of AAV-based gene therapies for patients with Bardet-Biedl Syndrome (BBS). To learn more about Axovia Therapeutics, visit their website.
We are game changers
The Jaguar Gene Therapy team is led by high-performing executives with proven experience in bringing gene therapies to market.